According to DexCom's latest financial reports the company's current revenue (TTM) is $3.62 B. In 2022 the company made a revenue of $2.90 B an increase over the years 2021 revenue that were of $2.44 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $3.62 B | 24.49% |
2022 | $2.90 B | 18.84% |
2021 | $2.44 B | 27.08% |
2020 | $1.92 B | 30.54% |
2019 | $1.47 B | 43.08% |
2018 | $1.03 B | 43.58% |
2017 | $0.71 B | 25.33% |
2016 | $0.57 B | 42.61% |
2015 | $0.40 B | 55.09% |
2014 | $0.25 B | 62% |
2013 | $0.16 B | 60.21% |
2012 | $99.86 M | 30.94% |
2011 | $76.26 M | 56.83% |
2010 | $48.63 M | 63.78% |
2009 | $29.69 M | 201.85% |
2008 | $9.83 M | 112.6% |
2007 | $4.62 M | 113.26% |
2006 | $2.16 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $93.02 B | 2,468.04% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $40.10 B | 1,007.28% | ๐บ๐ธ USA |
Medtronic MDT | $32.32 B | 792.25% | ๐ฎ๐ช Ireland |
Becton Dickinson BDX | $19.49 B | 438.11% | ๐บ๐ธ USA |
Edwards Lifesciences EW | $6.00 B | 65.77% | ๐บ๐ธ USA |
Tandem Diabetes Care
TNDM | $0.74 B | -79.36% | ๐บ๐ธ USA |
QuidelOrtho QDEL | $2.99 B | -17.24% | ๐บ๐ธ USA |
West Pharmaceutical WST | $2.94 B | -18.57% | ๐บ๐ธ USA |